Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Parkinson's Disease

Free Subscription 05.08.2019 1 Ann Neurol 1 BMC Neurol 1 J Neurochem 1 J Neurosci 5 Mov Disord 1 Neurobiol Dis 1 Neurology 1 Neuroscience 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. DEMBEK TA, Roediger J, Horn A, Reker P, et al
   Probabilistic Sweetspots Predict Motor Outcome for DBS in Parkinson's Disease.
   Ann Neurol. 2019 Aug 3. doi: 10.1002/ana.25567.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

2. VAN BALKOM TD, Berendse HW, van der Werf YD, Twisk JWR, et al
   COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
   BMC Neurol. 2019;19:179.
   PubMed     Text format     Abstract available
   
   

   
   J Neurochem

3. SORGDRAGER FJH, Vermeiren Y, Van Faassen HJR, Van Der Ley CP, et al
   Age- and Disease-Specific Changes of the Kynurenine Pathway in Parkinson's and Alzheimer's Disease.
   J Neurochem. 2019 Aug 3. doi: 10.1111/jnc.14843.
   PubMed     Text format     Abstract available
   
   

   
   J Neurosci

4. LUO S, Su Kang S, Wang ZH, Liu X, et al
   Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing its Antioxidative Activities in Parkinson's Disease.
   J Neurosci. 2019 Jul 29. pii: JNEUROSCI.0625-19.2019.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

5. AGALLIU I, Ortega RA, Luciano MS, Mirelman A, et al
   Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
   Mov Disord. 2019 Jul 26. doi: 10.1002/mds.27807.
   PubMed     Text format     Abstract available
   
   
6. OZTURK M, Abosch A, Francis D, Wu J, et al
   Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
   Mov Disord. 2019 Jul 26. doi: 10.1002/mds.27800.
   PubMed     Text format     Abstract available
   
   
7. KARAKATSANI ME, Blesa J, Konofagou EE
   Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson's disease.
   Mov Disord. 2019 Jul 30. doi: 10.1002/mds.27804.
   PubMed     Text format     Abstract available
   
   
8. HAQ IU, Snively BM, Sweadner KJ, Suerken CK, et al
   Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.
   Mov Disord. 2019 Jul 30. doi: 10.1002/mds.27801.
   PubMed     Text format     Abstract available
   
   
9. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
   Longitudinal analyses of cerebrospinal fluid alpha-Synuclein in prodromal and early Parkinson's disease.
   Mov Disord. 2019 Jul 30. doi: 10.1002/mds.27806.
   PubMed     Text format     Abstract available
   
   

   
   Neurobiol Dis

10. BURBULLA LF, Krainc D
    The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.
    Neurobiol Dis. 2019 Jul 25:104545. doi: 10.1016/j.nbd.2019.104545.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

11. SHIN JH, Park KW, Heo KO, Chung SJ, et al
    Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008053.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

12. DE LA MORA MP, Hernandez-Mondragon C, Crespo-Ramirez M, Rejon-Orantes J, et al
    Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia.
    Neuroscience. 2019 Jul 23. pii: S0306-4522(19)30510.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

13. STEVENSON SA, Ciucci MR, Kelm-Nelson CA
    Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2019;14:e0220734.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. LEE J, Pinares-Garcia P, Loke H, Ham S, et al
    Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Aug 1. pii: 1900406116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: